Literature DB >> 22071999

Clotting factor deficiency in early trauma-associated coagulopathy.

Sandro B Rizoli1, Sandro Scarpelini, Jeannie Callum, Bartolomeu Nascimento, Kenneth G Mann, Ruxandra Pinto, Jan Jansen, Homer C Tien.   

Abstract

BACKGROUND: Coagulopathic bleeding is a leading cause of in-hospital death after injury. A recently proposed transfusion strategy calls for early and aggressive frozen plasma transfusion to bleeding trauma patients, thus addressing trauma-associated coagulopathy (TAC) by transfusing clotting factors (CFs). This strategy may dramatically improve survival of bleeding trauma patients. However, other studies suggest that early TAC occurs by protein C activation and is independent of CF deficiency. This study investigated whether CF deficiency is associated with early TAC.
METHODS: This is a prospective observational cohort study of severely traumatized patients (Injury Severity Score ≥ 16) admitted shortly after injury, receiving minimal fluids and no prehospital blood. Blood was assayed for CF levels, thromboelastography, and routine coagulation tests. Critical CF deficiency was defined as ≤ 30% activity of any CF.
RESULTS: Of 110 patients, 22 (20%) had critical CF deficiency: critically low factor V level was evident in all these patients. International normalized ratio, activated prothrombin time, and, thromboelastography were abnormal in 32%, 36%, and 35%, respectively, of patients with any critically low CF. Patients with critical CF deficiency suffered more severe injuries, were more acidotic, received more blood transfusions, and showed a trend toward higher mortality (32% vs. 18%, p = 0.23). Computational modeling showed coagulopathic patients had pronounced delays and quantitative deficits in generating thrombin.
CONCLUSIONS: Twenty percent of all severely injured patients had critical CF deficiency on admission, particularly of factor V. The observed factor V deficit aligns with current understanding of the mechanisms underlying early TAC. Critical deficiency of factor V impairs thrombin generation and profoundly affects hemostasis.

Entities:  

Mesh:

Year:  2011        PMID: 22071999      PMCID: PMC3241929          DOI: 10.1097/TA.0b013e318232e5ab

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  47 in total

1.  Stability of coagulation proteins in frozen plasma.

Authors:  B Woodhams; O Girardot; M J Blanco; G Colesse; Y Gourmelin
Journal:  Blood Coagul Fibrinolysis       Date:  2001-06       Impact factor: 1.276

2.  Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines.

Authors:  Cynthia Luk; Kathleen M Eckert; Robert M Barr; Ian H Chin-Yee
Journal:  CMAJ       Date:  2002-06-11       Impact factor: 8.262

Review 3.  Factor V: a combination of Dr Jekyll and Mr Hyde.

Authors:  Kenneth G Mann; Michael Kalafatis
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

4.  Early coagulopathy predicts mortality in trauma.

Authors:  Jana B A MacLeod; Mauricio Lynn; Mark G McKenney; Stephen M Cohn; Mary Murtha
Journal:  J Trauma       Date:  2003-07

Review 5.  Clinical review: Fresh frozen plasma in massive bleedings - more questions than answers.

Authors:  Bartolomeu Nascimento; Jeannie Callum; Gordon Rubenfeld; Joao Baptista Rezende Neto; Yulia Lin; Sandro Rizoli
Journal:  Crit Care       Date:  2010-01-28       Impact factor: 9.097

Review 6.  Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials.

Authors:  S J Stanworth; S J Brunskill; C J Hyde; D B L McClelland; M F Murphy
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

7.  Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.

Authors:  D F O'Shaughnessy; C Atterbury; P Bolton Maggs; M Murphy; D Thomas; S Yates; L M Williamson
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

Review 8.  A review of studies on the effects of hemorrhagic shock and resuscitation on the coagulation profile.

Authors:  Anna M Ledgerwood; Charles E Lucas
Journal:  J Trauma       Date:  2003-05

9.  Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.

Authors:  Pratima Chowdary; Pratima Chowdhury; Anton G Saayman; Ulrike Paulus; George P Findlay; Peter W Collins
Journal:  Br J Haematol       Date:  2004-04       Impact factor: 6.998

10.  Acute traumatic coagulopathy.

Authors:  Karim Brohi; Jasmin Singh; Mischa Heron; Timothy Coats
Journal:  J Trauma       Date:  2003-06
View more
  34 in total

1.  Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.

Authors:  Gregory R Stettler; Ernest E Moore; Hunter B Moore; Geoffrey R Nunns; Julia R Coleman; Arthur Colvis; Arsen Ghasabyan; Mitchell J Cohen; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-09       Impact factor: 3.313

2.  Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-analytical considerations for proteomic investigations.

Authors:  Rosemary L Sparrow; Kasey Sze-Kei Chan
Journal:  J Proteomics       Date:  2012-07-16       Impact factor: 4.044

3.  The natural history and effect of resuscitation ratio on coagulation after trauma: a prospective cohort study.

Authors:  Matthew E Kutcher; Lucy Z Kornblith; Ryan F Vilardi; Brittney J Redick; Mary F Nelson; Mitchell Jay Cohen
Journal:  Ann Surg       Date:  2014-12       Impact factor: 12.969

4.  Prehospital Resuscitation of Traumatic Hemorrhagic Shock with Hypertonic Solutions Worsens Hypocoagulation and Hyperfibrinolysis.

Authors:  Matthew J Delano; Sandro B Rizoli; Shawn G Rhind; Joseph Cuschieri; Wolfgang Junger; Andrew J Baker; Michael A Dubick; David B Hoyt; Eileen M Bulger
Journal:  Shock       Date:  2015-07       Impact factor: 3.454

5.  Common haemostasis issues in major bleeding and critical illness.

Authors:  Divyansh Gulati; Alex Novak; Simon J Stanworth
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

6.  Rotational thromboelastometry thresholds for patients at risk for massive transfusion.

Authors:  Gregory R Stettler; Ernest E Moore; Geoffrey R Nunns; Jim Chandler; Erik Peltz; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Surg Res       Date:  2018-04-11       Impact factor: 2.192

7.  A Review of Radiation-Induced Coagulopathy and New Findings to Support Potential Prevention Strategies and Treatments.

Authors:  Ann R Kennedy; Amit Maity; Jenine K Sanzari
Journal:  Radiat Res       Date:  2016-07-26       Impact factor: 2.841

8.  Clinical and mechanistic drivers of acute traumatic coagulopathy.

Authors:  Mitchell Jay Cohen; Matt Kutcher; Britt Redick; Mary Nelson; Mariah Call; M Margaret Knudson; Martin A Schreiber; Eileen M Bulger; Peter Muskat; Louis H Alarcon; John G Myers; Mohammad H Rahbar; Karen J Brasel; Herb A Phelan; Deborah J del Junco; Erin E Fox; Charles E Wade; John B Holcomb; Bryan A Cotton; Nena Matijevic
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

9.  A principal component analysis of coagulation after trauma.

Authors:  Matthew E Kutcher; Adam R Ferguson; Mitchell J Cohen
Journal:  J Trauma Acute Care Surg       Date:  2013-05       Impact factor: 3.313

Review 10.  Management of bleeding and coagulopathy following major trauma: an updated European guideline.

Authors:  Donat R Spahn; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Rolf Rossaint
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.